Senzime AB (OTCPK:SNZZF)
$ 0.527 0 (0%) Market Cap: 68.54 Mil Enterprise Value: 66.06 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 59/100

Q2 2024 Senzime AB (publ) Earnings Call Transcript

Aug 26, 2024 / 09:00AM GMT
Release Date Price: $0.824 (-0.12%)
Klas Palin;Commissioned;Analyst
Penser Access

()-

Hello, and welcome to Carnegie and today's presentation with Senzime and its Q2 report. My name is Klas Palin, and I'm an equity analyst. And with me in the studio, I have Philip Siberg, who is CEO of Senzime. Very welcome, Philip.

Philip Siberg
Senzime AB - Chief Executive Officer

Thank you. Nice to be here.

Klas Palin;Commissioned;Analyst
Penser Access

()-

And it would be really interesting to hear your presentation of the Q2 report. Please go ahead, Philip.

Philip Siberg
Senzime AB - Chief Executive Officer

All right. Thank you, and thank you for listening-in into this. It's both a Q2 report, but also a little bit of an update today on some of our long- and short-term guidance and what we believe in the market. So for those of you who don't know Senzime, a quick recap. We are a Sweden headquartered medical device company.

We've developed a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot